Arkolith/Insider Trading/NVCT/Form 4

Bentsur Ron

Chairman & CEO, Director, 10% OwnerNuvectis Pharma, Inc. (NVCT) · full profile →Form 4 · filed Jan 9, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2026Grant(A)150K—$03.7M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-002500) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML